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Introduction: Congenital hypothyroidism is the most common cause of mental retardation in 
the world. The presence of hypothyroidism in fetal is lead to abnormalities in major organs, 
including nervous system and central skeleton. Aim of this study was to investigate 
epidemiologic situation of neonatal hypothyroidism in Ilam province between 2005 -2011. 
Materials and methods: This was a cross-sectional retrospective study. The number of 
27258 infants was born in Ilam province from 2005 till 2011. Among these infants who were 
enterned to screening program of congenital hypothyroidism, about 162 cases were identified 
as congenital hypothyroidism patients. The data were analyzed through SPSS software. 
Results: From identified patients, 95 infants (58.9%) were male. Incidence rate was 5 in 
1000 live birth. There was a significant correlation between birth weight and T4 level (P = 
0.02). The analysis showed that there is a significant relationship between gender of neonate 
and TSH level (P = 0.009).  
Conclusion: Prevalence of congenital hypothyroidism in Ilam province compare to other 
parts of country was high. Due to the importance of hypothyroidism in mental retardation, 
encouraging of parents to attend screening test seems to be necessary. 
Keywords:Congenital hypothyroidism, epidemiology, mental retardation 
Introduction 
Congenital hypothyroidism is one of the 
most common endocrine diseases and is 
the most important cause of mental 
retardation (1). Thyroid function is 
necessary for physical and mental growth 
of newborn(2) .The  Majority of  newborns 
with hypothyroidism have normal 
appearance  and don’t have specific 
symptoms of disease, so if diagnose will 
be only according to clinical symptoms, 
neonates will be infected with  irreversible 
complications such as deafness and mental 
retardation(3).  IQ impairments caused by 
the disease can be prevented, when the 
disease is diagnosed in the neonatal period 
(4, 5). 
The thyroid is a small gland located in the 
front of the neck that produces and 
secretes a hormone called thyroxin   that 
plays an important role in different cells 
metabolism and growth of the body. 
Influences of hormone are necessary for 
brain   growth and its development  .
Evaluation of thyroid function is very 
important and in the last three decades 
took too much attention. Nowadays, in 
most countries for on time diagnosis and 
treatment, hypothyroid screening test is 
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done at the time of neonate birth (6, 7, and 
8). For the First time hypothyroid 
screening studies started in North America 
(9). The first time in Iran CH screening 
was done by Dr. Azizi et al in 2008 (10). 
Hypothyroidism screening is one of the 
preventive programs that benefit- cost ratio 
is positive.  It is estimated that the cost for 
screening of any newborn would be 0.7 to 
1.60 $. The cost of diagnosis of a 
hypothyroidism neonate is 5000$. Benefit 
– cost ratio in several developed countries 
is different from 7.11 to 1 (11). 
In Iran, mentioned ratio was 15.1 (12). 
Prevalence of hypothyroidism in Iran is 
different for example: in Tehran, Shiraz, 
Esfahan was 1 in 914, 1 in 1433, and 1 in 
370 births, respectively (13). Totally 
prevalence of this disease in Iran is 
estimated 1 in 1000 live birth. Prevalence 
in the world is 1 in 3000 live birth. 
Incidence rate of congenital 
hypothyroidism in Iran comparison to 
other countries is high (14). According to 
conducted studies in different parts of  the 
world, the reasons of different prevalence 
of CH is  due to  various criteria for 
definite CH diagnosis, The 
hypothyroidism result from iodine 
deficiency lead to transient CH  (36, 37). 
Considering the fact that in most 
provinces, studies have been conducted 
about   congenital hypothyroidism, but 
such those studies were not conducted in 
Ilam despite of importance of this disease. 
This study was conducted to evaluate of 
the epidemiologic situation of congenital 
hypothyroidism from 2005 to 2011 in Ilam 
province. 
Materials and methods 
This study was descriptive and analytical. 
In this study information of patients were 
gathered from their documents in the 
Portal System of Prevention and Health 
Care Department of non-communicable 
diseases of Ilam University of Medical 
Sciences. By using check list, 
demographic variables including gender, 
settlement (urban or rural), birth weight, 
birth height, city residence and year of 
birth and clinical variables, including type 
of delivery, previous  parental illness, 
existence of disease in family, anomaly, 
TSH, T4, age of neonate in treatment 
starting, dose of taken drug and trend of 
disease, were collected 
Diagnosis criteria of hypothyroidism are 
measurement of TSH and T4 levels. If 
TSH will be less   than 5 mu/l test of 
congenital hypothyroidism is negative. If 
TSH level will be 5.1 – 9.9 µg/dl neonates 
is Suspicious to hypothyroidism, and TSH 
will be more than 9 mu/l is 
hypothyroidism. Normal range of T4 in 
blood is 5.6-13.7 mcg/dl, T4 level of less 
than 5.6 µg/dl and T4 level of more 
than13.7 µg /dl is hypothyroidism (15). 
If 3 years after treatment serum levels of 
TSH and T4 remain in the normal range is 
called Transient hypothyroidism. After this 
time any stable hypothyroidism in children 
with congenital hypothyroidism is 
permanent hypothyroidism (16). 
Data were analyzed using SPSS ver.16 
software. For descriptive purposes, 
frequency, mean and standard deviation 
were used. To calculate cumulative 
incidence, population of beginning 2005 
was used. Chi-square test, independent t-
test and Mann-Whitney with a significance 
level of less than 5% were considered to 
indicate a statistical significant difference. 
Because population changes are negligible 
during two consecutive years, and the 
probability of every born baby being 
diagnosed with hypothyroidism in the 
community is low (p is low), and high 
population (n is large), Thus new cases is 
n=Np, based on Poisson distribution mean 
and variance is equal to n (38). 
For comparison of incidence rate of 
congenital hypothyroidism in two 
consecutive years Poisson distributions 
can be used.  N1    is new hypothyroidism 
cases in second year, and n2 is new 
hypothyroidism cases in first year. For 
incidence rate comparing of 
hypothyroidism   during two consecutive 




years in Ilam province was used above 
method (38). 
Results 
Totally among 27258 births in Ilam 
province from 7 cities   during 2005-2011, 
162 neonates diagnosed with congenital 
hypothyroidism. Among these numbers 
more than half of those 95 neonates 
(58.9%) were male and fewer 65 (41.1%) 
were female. 
Abbdanan city had the highest rate of   
hypothyroidism and Sirvan-Chardavel had 
the lowest rate of disease (Table 1).
 
Table 1.  Incidence rate of congenital hypothyroidism in cities of Ilam province between 2005- 2011. 
Name of city 
Number of screened 
infants 
Number of diagnosed CH 
Incidence rate in 
1000 live births 
Ilam 11989 85 7 
Abdanan 2470 34 13 
Sirvan Chardavel 3798 8 1 
Ayvan 2619 11 4 
Malekshahi 1214 5 4 
Mehran 1512 8 5 
Dehloran 3656 11 3 
Total 27258 162 5 
 
In all cities Males were more affected to 
CH. Rang of TSH level of neonates was 
between 0.8 and 100 µg/dl. TSH mean of 
male (n=95) was 24.3±20.6. TSH mean of 
female (n=53) was 19.3±23.1. T4 mean in 
male was 48.2±25.5 and in female was 
53.4± 27.8. Birth weight mean in male was 
3.343±0.590kg and in female was 
3.295±0.575kg. Birth height mean in male 
was 48.2±2.45 cm and in female was 
48.8± 2.31cm.  
Among hypothyroidism cases TSH of 5.1 
% was less than 5µg/l, TSH of 26.6% was 
5.1-9.9µg/l and 68.3% was more than 
9.9µg/l.  T4 of 2.5% neonates was less 
than 5.6µg/dl, T4 of 16.1% was 5.6-
13.7µg/dl and 81.4 % had T4 level of more 
than 13.7µg/dl. Relationship between TSH 
and gender was statistical significance by 
Mann- Whitney test (P=0.009). This result 
showed that the mean of TSH in male 
(24.30±20.68µg/dl) was significantly more 
than the mean of TSH in female 
(20.68±19.33µg/dl).There was a 
significance versus correlation between 
TSH and T4 (r=-0.324, P=0.0001). In a 
way that increasing TSH cause T4 factor 
to reduce significantly and in some cases 
that TSH was very low, T4 was very high 
and contrary. Between birth weight and T4 
level was found a significance positive 
correlation (r=0.212, P=0.023). The results 
showed a significance relationship 
between height and weight and TSH level 
(P=0.0001).  
Among parents of patients 36 cases 
(22.2%) had relative degree 3, 15 cases 
(9.3%) had relative degree 4, and also 
more than half cases had no relative. 
Trend of disease in 108 cases (66.6%), was 
transient. In 5 cases (3.1%) was permanent 
hypothyroidism, in 22 cases (13.6%) was 
treating and there was 1 case lead to death . 
By Poisson distribution changes in 
hypothyroidism rate was significance 
between 2010-2011 (p<0.05), while there 
was no significant difference between 
other years. Congenital hypothyroidism 




rate was 5 in 1000 live births in Ilam 
province. 
For 141 patients (92.2%) treatment was 
started in less than 28 days, for 12 patients 
(7.8%) treatment was started in more than 
28 days.  
Discussion  
The Aim of this study was determination 
of epidemiologic aspects of congenital 
hypothyroidism   in Ilam province between 
2005 -2011. As mentioned,   a study like 
this study hasn’t been done throughout 
Ilam province, therefore, the data and 
results of this study seems to be candidate   
as a comprehensive report for other 
researches. Incidence rate of congenital 
hypothyroidism was 50 in 1000 live births, 
showing that prevalence of disease in Ilam 
province is high. In a study done by 
Hashemipour and other in Esfahan in 
2004, prevalence of hypothyroidism was 1 
in 370 neonates (17). In a study conducted 
by Ordukhani et al, in Tehran during 1997- 
2001, prevalence of hypothyroidism was 1 
in 914 live births (18). 
Also in a study conducted by Karamizadeh 
and Amir Hakimi in Shiraz, prevalence of 
congenital hypothyroidism was 1 in 1433 
live births (19). 
Prevalence of Hypothyroidism in different 
parts of  the world is different, it is 1 in 67 
in Nigeria (20), 1 in 781 in Pakistan (21), 1 
in 918 in some of Asian families(11) and 1 
in 10000 in Negro in America(23).  
Compare to different prevalence of CH in 
Iran and other countries, prevalence in 
Ilam is high (5 in 1000). High incidence 
rate of CH compare to other parts of Iran is 
due to that screening of hypothyroidism in 
Ilam province started in 2005 and maybe it 
was not very precise in early years and 
cases in primary years  were false positive, 
thus to clear incidence rate of CH in later 
years, conducting further researches is 
suggested . 
In current study the majority of patients 
had no relatives. Also in a study conducted 
by Hashemi pour in Esfahan 
hypothyroidism appearance in family 
marriage was not more (17). In a study 
conducted by Alizadeh and Colleagues in 
Khoy in 2009, hypothyroidism was more 
in neonates with family marriage (24). 
Scientific resources have mentioned sex 
ratio about 2.1 for congenital 
hypothyroidism (26), but in this study sex 
ratio was 0.7. In a study conducted by 
Namakin in Khorasan in 2009, sex ratio 
patients' male was 0.6% more than females 
(31). In a study in Yazd hypothyroidism   
prevalence was high in males (32). In 
Akhavirads study in Tehran sex ratio was 
1 (28). In a study done by Honarpisheh et 
al, sex ratio was 3.2 (29). In a study 
conducted in Italy relative risk female to 
male was 1.9 (30). In Australia this 
proportion was reported   2.5 to 1 (30). 
The majority of CH patients in our study 
and in a study conducted in Kurdistan (39) 
were male. Female gender is one of CH 
risk factor in references (40), but the 
reason of this difference in sex ratio is 
unclear . 
The average age of infants in time of 
treatment starting was 16 days. Only in 
1.2% treatment started more than 45 days.   
Start of treatment 14 days and 45 days 
after birth are ideal and is acceptable 
intervals on neonatal thyroid screening 
program (27-35).  In a study conducted by 
Ozra Akhi et al in Mazandaran in 2009, 
the average of treatment starting was 25 
days and for 11% of cases it started in 
more than 41 days (33). 
In current study was founded a 
significance relationship between gender 
and TSH but in research of Eftekhari in 
Kerman there was no significance 
relationship (1). 
Finally because of high prevalence of 
hypothyroidism in Ilam province and 
irreparable complications of disorder, 
encourage of parents to participate in 
hypothyroidism screening program and to 
continue treatment is necessary. 
Limitation of the study: This study was 
retrospective and data were carried out 
from existing health records, therefore 




missing data were due to incomplete 
document of patients.  
Conclusion  
Due to the importance of hypothyroidism 
in mental retardation, encouraging of 
parents to attend screening test is 
necessary. It is recommended to conduct 
future studies to gain the exact incidence 
rate of CH in Ilam province and to find 
cause of higher percentage of male with 
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